Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Korean Journal of Medicine ; : 519-522, 2014.
Artículo en Coreano | WPRIM | ID: wpr-192826

RESUMEN

Vibrio vulnificus is a halophilic gram-negative bacillus capable of causing severe to life-threatening infections in high-risk populations. Osteomyelitis caused by V. vulnificus is extremely rare, and a previously reported case had been associated with an adjacent soft-tissue infection. Herein we report the first case of vertebral osteomyelitis resulting from hematogenous spread of V. vulnificus gastroenteritis. The patient was successfully treated with a combination of cefotaxime and ciprofloxacin.


Asunto(s)
Humanos , Bacillus , Cefotaxima , Ciprofloxacina , Gastroenteritis , Osteomielitis , Espondilitis , Vibrio vulnificus , Vibrio
2.
The Korean Journal of Internal Medicine ; : 678-686, 2013.
Artículo en Inglés | WPRIM | ID: wpr-93087

RESUMEN

BACKGROUND/AIMS: The high mortality attributable to persistent methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in spite of glycopeptide treatment has heightened the need for early detection and intervention with alternative agents. The purpose of this study was to determine the clinical characteristics of and risk factors for persistent MRSA bacteremia. METHODS: All first episodes of significant MRSA bacteremia at a 710-bed academic medical center from November 2009 through August 2010 were recorded. Blood cultures were conducted at 3 days and every 2 to 3 days thereafter until clearance. Clinical characteristics and outcomes were compared between persistent MRSA bacteremia (> or = 7 days) and nonpersistent MRSA bacteremia (< or = 3 days). RESULTS: Of 79 patients with MRSA bacteremia during the study period, 31 (39.2%) had persistent MRSA bacteremia. The persistent MRSA bacteremia group had significantly higher 30-day mortality than the nonpersistent MRSA bacteremia group (58.1% vs. 16.7%, p < 0.001). Multivariate analysis indicated that metastatic infection at presentation (odds ratio [OR], 14.57; 95% confidence interval [CI], 3.52 to 60.34; p < 0.001) and delayed catheter removal in catheter-related infection (OR, 3.80; 95% CI, 1.04 to 13.88; p = 0.004) were independent predictors of persistent MRSA bacteremia. Patients with a time to blood culture positivity (TTP) of < 11.8 hours were at increased risk of persistent MRSA bacteremia (29.0% vs. 8.3%, p = 0.029). CONCLUSIONS: High mortality in patients with persistent MRSA bacteremia was noted. Early detection of metastatic infection and early removal of infected intravascular catheters should be considered to reduce the risk of persistent MRSA bacteremia. Further studies are needed to evaluate the role of TTP for predicting persistent MRSA bacteremia.


Asunto(s)
Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Centros Médicos Académicos , Antibacterianos/uso terapéutico , Infecciones Relacionadas con Catéteres/diagnóstico , Catéteres de Permanencia/efectos adversos , Comorbilidad , Remoción de Dispositivos , Capacidad de Camas en Hospitales , Modelos Logísticos , Staphylococcus aureus Resistente a Meticilina/efectos de los fármacos , Análisis Multivariante , Neoplasias/microbiología , Oportunidad Relativa , Estudios Prospectivos , República de Corea , Factores de Riesgo , Infecciones Estafilocócicas/diagnóstico , Factores de Tiempo , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA